{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:24:46Z","timestamp":1780093486034,"version":"3.54.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008993","name":"Sveu\u010dili\u0161te u Zagrebu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008993","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.pnpbp.2020.110016","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T20:49:57Z","timestamp":1591822197000},"page":"110016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients"],"prefix":"10.1016","volume":"105","author":[{"given":"Anja","family":"Dvojkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matea","family":"Nikolac Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sagud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Nedic Erjavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Mihaljevic Peles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubravka","family":"Svob Strac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjanka","family":"Vuksan Cusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucija","family":"Tudor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorana","family":"Kusevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Konjevod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Zivkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasa","family":"Jevtovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nela","family":"Pivac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2020.110016_bb0005","doi-asserted-by":"crossref","first-page":"109832","DOI":"10.1016\/j.pnpbp.2019.109832","article-title":"Activation of 5-HT1A postsynaptic receptors by NLX-101 results in functional recovery and an increase in neuroplasticity in mice with brain ischemia","volume":"99","author":"Aguiar","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0020","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.pnpbp.2006.03.025","article-title":"Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women","volume":"30","author":"Aydemir","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroimage.2013.10.002","article-title":"Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET","volume":"88","author":"Baldinger","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pnpbp.2014.12.002","article-title":"Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory","volume":"58","author":"B\u00e9try","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2015.10.034","article-title":"BDNF - a key transducer of antidepressant effects","volume":"102","author":"Bj\u00f6rkholm","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pnpbp.2018.06.003","article-title":"Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression","volume":"86","author":"Brunoni","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2020.110016_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188043","article-title":"Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression","volume":"12","author":"Burstein","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fnhum.2017.00315","article-title":"Yoga, meditation and mind-body health: increased BDNF, cortisol awakening response, and altered inflammatory marker expression after a 3-month yoga and meditation retreat","volume":"11","author":"Cahn","year":"2017","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.110016_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41398-019-0521-7","article-title":"Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies","volume":"9","author":"Carboni","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110016_bb0060","first-page":"102","article-title":"Can serotonin and fluoxetine levels in plasma and platelets predict clinical response in depression?","volume":"37","author":"Castrogiovanni","year":"2003","journal-title":"Psychopharmacol. Bull."},{"issue":"19","key":"10.1016\/j.pnpbp.2020.110016_bb0065","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1074\/jbc.M116.720029","article-title":"Brain-derived neurotrophic factor in megakaryocytes","volume":"291","author":"Chac\u00f3n-Fern\u00e1ndez","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.110016_bb0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ijnp\/pyy022","article-title":"A critical role of mitochondria in BDNF-associated synaptic plasticity after one-week vortioxetine treatment","volume":"21","author":"Chen","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110016_bb0075","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2012.05.025","article-title":"The concentrations of serum, plasma and platelet BDNF are all increased by treadmill VO\u2082max performance in healthy college men","volume":"519","author":"Cho","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"10128","key":"10.1016\/j.pnpbp.2020.110016_bb0080","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110016_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000478862","article-title":"Plasma BDNF level in major depression: biomarker of the Val66Met BDNF polymorphism and of the clinical course in Met carrier patients","volume":"75","author":"Colle","year":"2017","journal-title":"Neuropsychobiology"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110016_bb0090","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0006-3223(98)00344-8","article-title":"Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos","volume":"46","author":"Figueras","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0095","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pnpbp.2017.12.010","article-title":"Contrasting effects of vortioxetine and paroxetine on pineal gland biochemistry in a tryptophan-depletion model of depression in female rats","volume":"82","author":"Franklin","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110016_bb0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jnc.14114","article-title":"Adaptive dynamics of the 5-HT systems following chronic administration of selective serotonin reuptake inhibitors: a meta-analysis","volume":"142","author":"Fritze","year":"2017","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110016_bb0105","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/s41598-019-45976-5","article-title":"Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy","volume":"9","author":"Gejl","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2020.110016_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajp.2015.10.006","article-title":"Comparison of efficacy, safety and brain derived neurotrophic factor (BDNF) levels in patients of major depressive disorder, treated with fluoxetine and desvenlafaxine","volume":"18","author":"Ghosh","year":"2015","journal-title":"Asian J. Psychiatr."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110016_bb0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/17460441.2019.1546691","article-title":"Vortioxetine: a novel antidepressant for the treatment of major depressive disorder","volume":"14","author":"Gonda","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"issue":"7","key":"10.1016\/j.pnpbp.2020.110016_bb0120","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jpsychires.2013.03.006","article-title":"Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only","volume":"47","author":"Haghighi","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2020.110016_bb0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110016_bb0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/JCP.0000000000001014","article-title":"Effects of cytochrome P450 2c19 genetic polymorphisms on responses to escitalopram and levels of brain-derived neurotrophic factor in patients with panic disorder","volume":"39","author":"He","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.110016_bb0135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pnpbp.2017.07.008","article-title":"Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats","volume":"82","author":"Hlavacova","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2020.110016_bb0140","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/jsm.12980","article-title":"Effect of vortioxetine vs. escitalopram on sexual functioning in adults with well-treated major depressive disorder experiencing SSRI-induced sexual dysfunction","volume":"12","author":"Jacobsen","year":"2015","journal-title":"J. Sex. Med."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110016_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.43","article-title":"The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment","volume":"7","author":"Jiang","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110016_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","article-title":"Decreased serum brain-derived neurotrophic factor levels in major depressed patients","volume":"109","author":"Karege","year":"2002","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.pnpbp.2020.110016_bb0155","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/da.22832","article-title":"Response rate profiles for major depressive disorder: characterizing early response and longitudinal nonresponse","volume":"35","author":"Kelley","year":"2018","journal-title":"Depress. Anxiety"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.110016_bb0160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/S1461145710000738","article-title":"Blood BDNF concentrations reflect brain-tissue BDNF levels across species","volume":"14","author":"Klein","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110016_bb0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1037\/pha0000264","article-title":"The effect of selective serotonin reuptake inhibitors in healthy subjects revisited: a systematic review of the literature","volume":"27","author":"Knorr","year":"2019","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.110016_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039212","article-title":"Plasma brain-derived neurotrophic factor levels predict the clinical outcome of depression treatment in a naturalistic study","volume":"7","author":"Kurita","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0175","first-page":"128","article-title":"Brain derived neurotrophic factor (BDNF) levels in depressed women treated with open-label escitalopram","volume":"25","author":"Ladea","year":"2013","journal-title":"Psychiatr. Danub."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110016_bb0180","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4306\/pi.2010.7.4.231","article-title":"The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment","volume":"7","author":"Lee","year":"2010","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.pnpbp.2020.110016_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2020.110016_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.06.007","article-title":"Effects of vortioxetine and fluoxetine on the level of brain derived neurotrophic factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats","volume":"142","author":"Lu","year":"2018","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110016_bb0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40520-014-0194-2","article-title":"Effects of escitalopram on serum BDNF levels in elderly patients with depression: a preliminary report","volume":"26","author":"Martocchia","year":"2014","journal-title":"Aging Clin. Exp. Res."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.110016_bb0200","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpsychires.2008.03.014","article-title":"Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine","volume":"43","author":"Matrisciano","year":"2009","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110016_bb0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1160\/TH03-05-0330","article-title":"The influence of selective serotonin reuptake inhibitors on human platelet serotonin","volume":"91","author":"Maurer-Spurej","year":"2004","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.pnpbp.2020.110016_bb1000","first-page":"97","article-title":"Plasma brain-derived neurotrophic factor (BDNF) concentration and the BDNF Val66Met polymorphism in suicide: a prospective study in patients with depressive disorder.","volume":"12","author":"Ming","year":"2019","journal-title":"Pharmgenomics Pers Med"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110016_bb0210","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"7\u20138","key":"10.1016\/j.pnpbp.2020.110016_bb0215","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0278-5846(02)00259-2","article-title":"The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression","volume":"26","author":"Muck-Seler","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0225","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.3390\/ijms20246235","article-title":"Vortioxetine subchronically activates serotonergic transmission via desensitization of serotonin 5-HT1A receptor with 5-HT3 receptor inhibition in rats","volume":"20","author":"Okada","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110016_bb0230","article-title":"Protective effects of vortioxetine in predator scent stress model of post-traumatic stress disorder in rats: role on neuroplasticity and apoptosis","volume":"70","author":"Ozbeyli","year":"2019","journal-title":"J. Physiol. Pharmacol."},{"issue":"12","key":"10.1016\/j.pnpbp.2020.110016_bb0235","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110016_bb0240","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/pcn.12609","article-title":"Effects of maternal separation and antidepressant drug on epigenetic regulation of the brain-derived neurotrophic factor exon I promoter in the adult rat hippocampus","volume":"72","author":"Park","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.110016_bb0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-1781(97)00120-0","article-title":"Hypothalamic-pituitary-adrenal axis activity and platelet 5-HT concentrations in depressed patients","volume":"73","author":"Pivac","year":"1997","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110016_bb0255","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0278-5846(03)00105-2","article-title":"Long-term sertraline treatment and peripheral biochemical markers in female depressed patients","volume":"27","author":"Pivac","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110016_bb0260","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0169-328X(95)00250-V","article-title":"Permeability at the blood-brain barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF","volume":"36","author":"Poduslo","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.110016_bb0265","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/ijms18061189","article-title":"Stability of BDNF in human samples stored up to 6 months and correlations of serum and EDTA-plasma concentrations","volume":"18","author":"Polyakova","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt A","key":"10.1016\/j.pnpbp.2020.110016_bb0270","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuropharm.2016.09.024","article-title":"Subchronic vortioxetine treatment -but not escitalopram- enhances pyramidal neuron activity in the rat prefrontal cortex","volume":"113","author":"Riga","year":"2017","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110016_bb0275","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00702-006-0555-x","article-title":"Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects","volume":"114","author":"Roggenbach","year":"2007","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"17","key":"10.1016\/j.pnpbp.2020.110016_bb0280","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s00213-016-4364-0","article-title":"A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment","volume":"233","author":"Sagud","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0285","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2018.12.033","article-title":"Effects of escitalopram and ibuprofen on a depression-like phenotype induced by chronic stress in rats","volume":"696","author":"Seo","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110016_bb0290","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5498\/wjp.v6.i1.84","article-title":"Are the changes in the peripheral brain-derived neurotrophic factor levels due to platelet activation?","volume":"6","author":"Serra-Mill\u00e0s","year":"2016","journal-title":"World J. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110016_bb0295","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1440-1819.2012.02355.x","article-title":"Platelet count alterations associated with escitalopram, venlafaxine and bupropion in depressive patients","volume":"66","author":"Song","year":"2012","journal-title":"Psych. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.110016_bb2000","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.euroneuro.2013.01.002","article-title":"5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects","volume":"23","author":"Stenkrona","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0300","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/ijmr.IJMR_1566_17","article-title":"Reduced brain-derived neurotrophic factor concentration related to coronary heart disease","volume":"150","author":"Sustar","year":"2019","journal-title":"Ind. J. Med. Res."},{"issue":"11","key":"10.1016\/j.pnpbp.2020.110016_bb0305","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1017\/S146114571400073X","article-title":"Immobility responses between mouse strains correlate with distinct hippocampal serotonin transporter protein expression and function","volume":"17","author":"Tang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.110016_bb0310","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jad.2017.11.053","article-title":"The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: a short-term, randomized, double-blind, exploratory study versus escitalopram","volume":"227","author":"Vieta","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2020.110016_bb0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2015.12.012","article-title":"Vortioxetine promotes maturation of dendritic spines in vitro: a comparative study in hippocampal cultures","volume":"103","author":"Waller","year":"2016","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.pnpbp.2020.110016_bb0330","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1177\/0269881115599387","article-title":"Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: part 1, a pharmacokinetic\/pharmacodynamic comparison with paroxetine in healthy men","volume":"29","author":"Wilson","year":"2015","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2020.110016_bb0335","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.pnpbp.2011.06.013","article-title":"Serum BDNF levels before treatment predict SSRI response in depression","volume":"35","author":"Wolkowitz","year":"2011","journal-title":"Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2020.110016_bb0340","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.pnpbp.2011.06.013","article-title":"Serum BDNF levels before treatment predict SSRI response in depression","volume":"35","author":"Wolkowitz","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110016_bb3000","series-title":"Global Health Estimates","article-title":"Depression and Other Common Mental Disorders","year":"2017"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110016_bb0345","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/psyg.12426","article-title":"Efficacy of vortioxetine combined cognitive behaviour intervention therapy on brain-derived neurotrophic factor level on depressive patients","volume":"19","author":"Yan","year":"2019","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0350","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4306\/pi.2014.11.1.84","article-title":"Serum levels of brain-derived neurotrophic factor at 4 weeks and response to treatment with SSRIs","volume":"11","author":"Yoshimura","year":"2014","journal-title":"Psychiatry Investig."},{"issue":"11","key":"10.1016\/j.pnpbp.2020.110016_bb0355","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.2174\/0929867311320110003","article-title":"Platelet SERT as a peripheral biomarker of serotonergic neurotransmission in the central nervous system","volume":"20","author":"Yubero-Lahoz","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110016_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172270","article-title":"Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.110016_bb0365","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2018.07.033","article-title":"Platelet serotonin and serotonin transporter as peripheral surrogates in depression and anxiety patients","volume":"834","author":"Zhuang","year":"2018","journal-title":"Eur. J. Pharmacol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584620303328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584620303328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:57:03Z","timestamp":1759521423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584620303328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":71,"alternative-id":["S0278584620303328"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110016","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110016"}}